DK0464105T3 - Melaninkoncentrerende hormoner og DNA til ekspression af samme - Google Patents
Melaninkoncentrerende hormoner og DNA til ekspression af sammeInfo
- Publication number
- DK0464105T3 DK0464105T3 DK90905279.7T DK90905279T DK0464105T3 DK 0464105 T3 DK0464105 T3 DK 0464105T3 DK 90905279 T DK90905279 T DK 90905279T DK 0464105 T3 DK0464105 T3 DK 0464105T3
- Authority
- DK
- Denmark
- Prior art keywords
- mch
- glu
- peptides
- ala
- rat
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 101800002739 Melanin-concentrating hormone Proteins 0.000 abstract 6
- 102400001132 Melanin-concentrating hormone Human genes 0.000 abstract 6
- ORRDHOMWDPJSNL-UHFFFAOYSA-N melanin concentrating hormone Chemical compound N1C(=O)C(C(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(NC(=O)C(N)CC(O)=O)C(C)O)CCSC)CSSCC(C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)C)C(O)=O)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C1CC1=CC=C(O)C=C1 ORRDHOMWDPJSNL-UHFFFAOYSA-N 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 239000002243 precursor Substances 0.000 abstract 3
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 2
- 101500028288 Homo sapiens Melanin-concentrating hormone Proteins 0.000 abstract 2
- 101500025368 Rattus norvegicus Melanin-concentrating hormone Proteins 0.000 abstract 2
- 108020004635 Complementary DNA Proteins 0.000 abstract 1
- 102400000739 Corticotropin Human genes 0.000 abstract 1
- 101800000414 Corticotropin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 abstract 1
- 101710200814 Melanotropin alpha Proteins 0.000 abstract 1
- 206010029098 Neoplasm skin Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical group [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 abstract 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 abstract 1
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 abstract 1
- 229960000258 corticotropin Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/326,984 US5049655A (en) | 1989-03-22 | 1989-03-22 | Melanin-concentrating hormones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0464105T3 true DK0464105T3 (da) | 1997-01-06 |
Family
ID=23274624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90905279.7T DK0464105T3 (da) | 1989-03-22 | 1990-03-20 | Melaninkoncentrerende hormoner og DNA til ekspression af samme |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US5049655A (fr) |
| EP (1) | EP0464105B1 (fr) |
| JP (1) | JP2944202B2 (fr) |
| AT (1) | ATE141288T1 (fr) |
| CA (1) | CA2046900C (fr) |
| DE (1) | DE69028101T2 (fr) |
| DK (1) | DK0464105T3 (fr) |
| WO (1) | WO1990011295A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849708A (en) * | 1995-06-06 | 1998-12-15 | Joslin Diabetes Center, Inc. | Promotion of eating behavior |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| AU1802000A (en) * | 1998-12-28 | 2000-07-24 | Takeda Chemical Industries Ltd. | Screening method |
| GB9924351D0 (en) * | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
| EP1255770A4 (fr) * | 2000-02-03 | 2004-12-08 | Merck & Co Inc | Analogues de l'hormone concentratrice de la melanine |
| US7220720B2 (en) * | 2000-02-03 | 2007-05-22 | Merk & Co., Inc. | Melanin-concentrating hormone analogs |
| US6809104B2 (en) * | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| US20070135425A1 (en) * | 2001-05-04 | 2007-06-14 | Amgen Inc. | Fused heterocyclic compounds |
| GB0112343D0 (en) * | 2001-05-21 | 2001-07-11 | Norske Stats Oljeselskap | Well treatment |
| US7314861B2 (en) * | 2001-05-31 | 2008-01-01 | Merck & Co., Inc. | Melanin-concentrating hormone analogs |
| CA2456964A1 (fr) * | 2001-08-08 | 2003-02-20 | Merck & Co., Inc. | Antagonistes d'hormone concentrant la melanine |
| CA2473229A1 (fr) * | 2002-01-09 | 2003-07-24 | Merck & Co., Inc. | Agonistes selectifs du recepteur de type 1 de l'hormone de melano-concentration |
| KR20030066187A (ko) * | 2002-02-05 | 2003-08-09 | 나드리화장품주식회사 | 미백 화장료 조성물 |
| CN101134757A (zh) * | 2002-11-06 | 2008-03-05 | 安姆根有限公司 | 稠合杂环化合物 |
| CA2569782C (fr) | 2004-06-17 | 2011-09-27 | Statoil Asa | Prevention ou reduction de la migration de particules dans des formations d'hydrocarbures |
| CA2569770C (fr) * | 2004-06-17 | 2012-02-21 | Statoil Asa | Regulation de l'eau dans une formation souterraine |
| CA2604220A1 (fr) * | 2005-04-26 | 2006-11-02 | Rune Godoey | Procede de construction et de traitement de puits |
| KR100839194B1 (ko) | 2006-12-14 | 2008-06-17 | 부경대학교 산학협력단 | 양식 넙치의 멜라닌농축호르몬 |
| GB2450502B (en) * | 2007-06-26 | 2012-03-07 | Statoil Asa | Microbial enhanced oil recovery |
| EP2190453A2 (fr) * | 2007-09-11 | 2010-06-02 | Mondobiotech Laboratories AG | Utilisation de la trp6-triptoréline et du d-leu6-leuprolide comme agent thérapeutique |
| WO2009043523A2 (fr) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Utilisation d'un peptide en tant qu'agent thérapeutique |
-
1989
- 1989-03-22 US US07/326,984 patent/US5049655A/en not_active Expired - Lifetime
-
1990
- 1990-03-20 DE DE69028101T patent/DE69028101T2/de not_active Expired - Fee Related
- 1990-03-20 EP EP90905279A patent/EP0464105B1/fr not_active Expired - Lifetime
- 1990-03-20 DK DK90905279.7T patent/DK0464105T3/da active
- 1990-03-20 WO PCT/US1990/001492 patent/WO1990011295A1/fr not_active Ceased
- 1990-03-20 AT AT90905279T patent/ATE141288T1/de active
- 1990-03-20 JP JP2505271A patent/JP2944202B2/ja not_active Expired - Lifetime
- 1990-03-20 CA CA002046900A patent/CA2046900C/fr not_active Expired - Lifetime
-
1994
- 1994-03-09 US US08/208,531 patent/US5449766A/en not_active Expired - Lifetime
-
1995
- 1995-05-23 US US08/447,613 patent/US5530095A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2046900A1 (fr) | 1990-09-23 |
| US5449766A (en) | 1995-09-12 |
| JP2944202B2 (ja) | 1999-08-30 |
| ATE141288T1 (de) | 1996-08-15 |
| WO1990011295A1 (fr) | 1990-10-04 |
| EP0464105A1 (fr) | 1992-01-08 |
| DE69028101T2 (de) | 1997-03-06 |
| CA2046900C (fr) | 2000-08-22 |
| JPH04503812A (ja) | 1992-07-09 |
| EP0464105A4 (en) | 1992-08-12 |
| US5530095A (en) | 1996-06-25 |
| US5049655A (en) | 1991-09-17 |
| DE69028101D1 (de) | 1996-09-19 |
| EP0464105B1 (fr) | 1996-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0464105T3 (da) | Melaninkoncentrerende hormoner og DNA til ekspression af samme | |
| Savage et al. | Epidermal growth factor and a new derivative: rapid isolation procedures and biological and chemical characterization | |
| Kangawa et al. | Structural identification of β-and γ-human atrial natriuretic polypeptides | |
| Thomas et al. | Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. | |
| Goldstein et al. | Thymosins: chemistry and biological properties in health and disease | |
| KR100345254B1 (ko) | 생물학적샘플속의인터루킨12또는인터루킨12의p40아단위를검출하는방법 | |
| Prinz et al. | T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products | |
| ES2426420T3 (es) | Péptidos de queratina bioactivos | |
| CHOCHINOV et al. | Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay | |
| Hollenberg et al. | Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts | |
| CA1244407A (fr) | Peptide auriculaire ayant des proprietes natriuretiques, diuretiques et vasodilatatrices | |
| KR960007604B1 (ko) | 인체 렐락신 또는 그 유사체를 제조하는 방법 | |
| US7008925B1 (en) | Melanocortin 1 receptor selective compounds | |
| Lernhardt et al. | T-cell hybridomas which produce B lymphocyte replication factors only | |
| GB2304047A (en) | Pharmaceutical compositions containing cytokines | |
| KR100424553B1 (ko) | 사람인터루킨-6억제제 | |
| ES2173856T3 (es) | Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas. | |
| JPS63122699A (ja) | ペプチド | |
| TAKAOKA et al. | Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type) | |
| CA2566776C (fr) | Procede permettant d'ameliorer un etat inflammatoire de la peau | |
| MXPA01011158A (es) | Factor de crecimiento homologo zvegf4. | |
| JPH03500529A (ja) | 増殖因子 | |
| JP3160013B2 (ja) | 新規ペプチド | |
| Vaughan et al. | DNA encoding NEI and NGE peptides | |
| CA2075240A1 (fr) | Proteine chondromoduline-ii |